Medicine Grand Rounds: Inflammatory Bowel Diseases: Bedside to Bench and Back

When:
November 13, 2019 @ 8:00 am – 9:00 am
2019-11-13T08:00:00-08:00
2019-11-13T09:00:00-08:00
Where:
LKSC Berg Hall
291 Campus Drive
Palo Alto
CA 94305
Cost:
Free
Contact:
Talia Ochoa
Medicine Grand Rounds: Inflammatory Bowel Diseases: Bedside to Bench and Back @ LKSC Berg Hall | Palo Alto | California | United States

Presenters: Sarah Streett, MD, and Aida Habtezion, MD, MSc

Streett: Clinical Associate Professor of Gastroenterology and Hepatology, Stanford

Habtezion: Associate Professor of Gastroenterology and Hepatology, Stanford

Streett: Sarah Streett, MD, is the Clinical Director of Inflammatory Bowel Disease at Stanford and is passionate about taking care of people with IBD. She is a national expert in the treating of complex IBD and is expanding our services to offer multi-disciplinary care and opportunities for clinical research participation. In 2018 she received the Champion of Hope Award from the Crohn’s and Colitis Foundation and serves on their Medical Advisory Board. Her interests are in fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and in the role that the microbiome and diet play its pathogenesis. She is one of the investigators in the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy and applying new technologies to individualizing therapy for IBD.

Streett has a national leadership role in the American Gastroenterological Association, where has been Chair of the Practice Management and Economics Committee, as well as Chair of the AGA’s initiatives on Obesity. She currently serves on the Government Affairs Committee and is a special government employee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patient’s personalized care based on the latest therapies for the treatment of IBD.

Habtezion: Dr. Habtezion is a physician scientist, appointed as the endowed Ballinger-Swindells Scholar, Associate Professor in the Department of Medicine, Division of Gastroenterology & Hepatology and Institute for Immunity, Transplantation and Infection and Associate Dean for Academic Affairs at Stanford School of Medicine. Her research, which addresses leukocyte recruitment and immune responses in diseases affecting the pancreas and the intestine. In 2011-2012 she was named digestive disease investigator and in 2012-2015 she received the Robert Wood Johnson Harold Amos Medical Faculty Development Award. In 2013 she received the Division of Gastroenterology & Hepatology Teaching Award and in 2016 the Immunology Faculty Mentor of the Year. In 2017, she received Synergy Award from the Kenneth Rainin Foundation for her research in inflammatory bowel disease (IBD), she was elected into the American Society for Clinical Investigation and also into the American Pancreas Association Council. Her lab supported by the NIH, Department of Defense, and foundation grants studies leukocyte trafficking and immune responses pertaining to gastrointestinal organs in states of both health and disease. She and her group initiated the first Stanford IBD registry, which has been instrumental for translational research in IBD. A Major project in her lab pertains to understanding immune responses and disease heterogeneity with goals of identifying immune signatures that can be used to improve the diagnosis and treatment of IBD.